The Amyloidosis Center at Boston University School of Medicine and Boston Medical Center is recognized internationally as a leader in basic and clinical research on amyloidosis and related diseases. Recently, Vaishali Sanchorawala, MD was appointed the new director. The Center is unique in its approach, providing exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research.
Our mission is to serve as a:
- Referral center for evaluation and treatment of patients with amyloid diseases
- Coordinating center for clinical trials and laboratory research on systemic amyloidosis.
- Reference laboratory for amyloid pathology and molecular diagnostics
- Resource for information on amyloidosis for patients and their families, physicians, and scientists
The Amyloidosis Center coordinates the multidisciplinary evaluation of patients with amyloidosis by subspecialists who are experts in amyloid diseases. The clinical program works closely with the Stem Cell Transplant Program in the Section of Hematology-Oncology, Department of Medicine, directed by Vaishali Sanchorawala, MD, and with the Clinical Trials Office. Trials and treatment are available for all major forms of amyloidosis. John Berk, MD, assistant director, directs clinical trials for the familial forms of amyloidosis, as well as the Airway Clinic.
Activities in the Alan and Sandra Gerry Amyloid Research Laboratory at Boston University School of Medicine are directed by Lawreen Connors, PhD and include the Amyloidosis Reference Laboratory as well as basic research on amyloidosis, in collaboration with other laboratories at Boston University and elsewhere.